Patient & Survivor Care
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.
Feature
Tucatinib-Trastuzumab Benefit ‘Remarkable’ in HER2-positive mCRC
Oncologists emphasize that the tucatinib-trastuzumab combination represents a major breakthrough.
Feature
Outside the Guidelines: Prostate Cancer Screening Overused in Older Men
Experts address potential harms of screening for prostate cancer in patients with low life expectancy.
From the Journals
Hypofractionated Radiotherapy Limits Toxic Effects in Cervical Cancer
Researchers analyze outcomes from patients undergoing hypofractionated IMRT for cervical cancer after radical hysterectomy and pelvic lymph node...
Conference Coverage
Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies
Survey respondents classify and grade morbilliform, psoriasiform, and papulopustular rashes based on a review of photographs and text descriptions...
From the Journals
Darker Skin Tones Underrepresented on Skin Cancer Education Websites
How inclusive is the representation of skin tones in photos of skin cancer on government websites?
Conference Coverage
New mRNA Vaccines in Development for Cancer and Infections
Different forms and designations of mRNA vaccines are used, depending on the application and desired effect.
From the Journals
Can a Risk Score Predict Kidney Injury After Cisplatin?
Researchers have developed a risk algorithm to predict acute kidney injury after cisplatin administration and tested it using data from six US...
Feature
Can Nectin-4 Expression Predict Response to Bladder Cancer Treatment?
New research investigates whether Nectin-4 amplification can predict response to enfortumab vedotin (EV) in patients with metastatic urothelial...
From the Journals
Negative Colonoscopy? 15-Year Screening Interval May Be Safe
Researchers compare patients who had a first colonoscopy with negative findings for CRC with matched controls who either did not have a...
From the Journals
Do Patients Benefit from Cancer Trial Participation?
Researchers conduct a meta-analysis comprising 141 comparisons of an investigational drug and a control treatment, which include immunotherapies...